These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 588347)

  • 21. Prognostic significance of lymph node histology in patients with squamous cell carcinoma of the larynx, pharynx, or oral cavity.
    Berlinger NT; Tsakraklides V; Pollak K; Adams GL; Yang M; Good RA
    Laryngoscope; 1976 Jun; 86(6):792-803. PubMed ID: 778514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
    Maisel RH; Ogura JH
    Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nonspecific immunity in laryngeal cancer].
    Zawisza E; Fruba J; Tarchalska B; Kendziorek A; Szlenk Z; Strauss M; Swierczyński Z
    Pol Tyg Lek; 1985 Oct 7-14; 40(40-41):1147-9. PubMed ID: 3878964
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
    Hollinshead AC
    Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic significance of the reaction of regional lymph nodes and lymphoid-cellular infiltration of the tumor in laryngeal cancer].
    Ol'khovskaia IG; Matiakin EG
    Vestn Otorinolaringol; 1992; (2):12-4. PubMed ID: 1632026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Various indicators of cellular immunity in laryngeal cancer].
    Sudoma AS
    Zh Ushn Nos Gorl Bolezn; 1978; (6):47-9. PubMed ID: 735358
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphometric study of the latero-cervical lymph nodes in laryngeal carcinoma].
    Resta L; Fiorella R; Grammatica L; Ricco R
    Pathologica; 1983; 75(1035):67-80. PubMed ID: 6348679
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vivo tissue distribution of laryngeal cancer drained lymph node lymphocytes in tumor-bearing mice].
    Wu Y; Guo M
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):197-9. PubMed ID: 8745454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of cellular immune response in clinical use to assess the invasiveness and progression of squamous cell carcinoma of the larynx].
    Starska K
    Otolaryngol Pol; 2010; 64(3):185-7. PubMed ID: 20731211
    [No Abstract]   [Full Text] [Related]  

  • 32. Depressed lectin-dependent and enhanced antibody-dependent cell-mediated cytotoxicity in patients with stage I cancer of the larynx.
    Perl A; Repassy G; Gonzalez-Cabello R; Lang I; Gergely P
    Nat Immun Cell Growth Regul; 1986; 5(2):100-6. PubMed ID: 3487714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-host relationship and its implications in the treatment and long-term prognosis of laryngeal cancer. Critical observations on the TNM system of tumour classification.
    Sala O
    Acta Otorhinolaryngol Belg; 1976; 30(4):371-8. PubMed ID: 1087526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
    Bulbuk GA
    Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes.
    O'Sullivan GC; Corbett AR; Shanahan F; Collins JK
    J Immunol; 1996 Nov; 157(10):4717-20. PubMed ID: 8906853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of red-cell immunology in patients with laryngeal carcinoma].
    Sun Y; Liu Y; Liu Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(6):351-3. PubMed ID: 8762526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On certain immunologic aspects of laryngeal carcinoma].
    Cortesina G; Busca GP; Cherubini E
    Minerva Otorinolaringol; 1968; 18(3):137-9. PubMed ID: 5740918
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of salivary IgA in laryngeal carcinoma].
    Lejska M; Popov P
    Cesk Otolaryngol; 1985 Nov; 34(6):337-41. PubMed ID: 4064129
    [No Abstract]   [Full Text] [Related]  

  • 39. [Importance of function studies in the immunological assessment of laryngeal cancer patients].
    Denaro A; Caruso R; Rossi M; Campo M; Iacona G; Mangano A; Stivala F
    Acta Otorhinolaryngol Ital; 1983; 3(6):625-39. PubMed ID: 6675414
    [No Abstract]   [Full Text] [Related]  

  • 40. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.